Stockreport

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy? [Yahoo! Finance]

Bioventus Inc. - Class A  (BVS) 
PDF This upside can be attributed to the encouraging sales performance across its business segments, based on which management raised the 2024 guidance twice this year. In [Read more]